This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Alzheimer Disease  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Nutritional and Metabolic Disorders  • Nutrition/ Malnutrition  • Alert me on articles by topic

Marian L. Evatt, MD, MS; Mahlon R. DeLong, MD; Natasha Khazai, MD; Ami Rosen, MS; Shirley Triche, RN; Vin Tangpricha, MD, PhD

Arch Neurol. 2008;65(10):1348-1352.

Background  A role for vitamin D deficiency in Parkinson disease (PD) has recently been proposed.

Objective  To compare the prevalence of vitamin D deficiency in a research database cohort of patients with PD with the prevalence in age-matched healthy controls and patients with Alzheimer disease (AD).

Design  Survey study and blinded comparison of plasma 25-hydroxyvitamin D (25[OH]D) concentrations of stored samples in a clinical research database at Emory University School of Medicine.

Setting  Referral center (PD and AD patients), primary care clinics, and community setting (controls).

Participants  Participants were recruited into the study between May 1992 and March 2007. Every fifth consecutively enrolled PD patient was selected from the clinical research database. Unrelated AD (n = 97) and control (n = 99) participants were randomly selected from the database after matching for age, sex, race, APOE genotype, and geographic location.

Main Outcome Measures  Prevalence of suboptimal vitamin D and mean 25(OH)D concentrations.

Results  Significantly more patients with PD (55%) had insufficient vitamin D than did controls (36%) or patients with AD (41%; P = .02, ²test). The mean (SD) 25(OH)D concentration in the PD cohort was significantly lower than in the AD and control cohorts (31.9 [13.6] ng/mL vs 34.8 [15.4] ng/mL and 37.0 [14.5] ng/mL, respectively; P = .03).

Conclusions  This report of 25(OH)D concentrations in a predominantly white PD cohort demonstrates a significantly higher prevalence of hypovitaminosis in PD vs both healthy controls and patients with AD. These data support a possible role of vitamin D insufficiency in PD. Further studies are needed to determine the factors contributing to these differences and elucidate the potential role of vitamin D in pathogenesis and clinical course of PD.

Author Affiliations: Division of Movement Disorders, Department of Neurology (Drs Evatt and DeLong and Mss Rosen and Triche), and Division of Endocrinology, Diabetes, and Lipids, Department of Medicine (Drs Khazai and Tangpricha), Emory University School of Medicine, Atlanta, Georgia.

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2008;65(10):1278-1280.
FULL TEXT